|
WO2020236693A1
|
|
Morphine-induced respiratory depression: behavioral, phrenic and brainstem respiratory neuronal evidence
|
|
WO2020232353A1
|
|
Sensors and methods using electrochemiluminescence of metal nanoclusters
|
|
WO2020210003A2
|
|
Virus-like particles and uses thereof
|
|
US2020138810A1
|
|
Treatment of aneurysms
|
|
WO2020131746A1
|
|
Predicting dcis recurrence risk using a machine learning-based high-content image analysis approach
|
|
WO2020118245A1
|
|
Quantitative centrosomal amplification score to predict local recurrence of ductal carcinoma in situ
|
|
WO2020106717A1
|
|
Compounds for photodynamic therapy and related uses
|
|
WO2020081829A1
|
|
Treatment of acanthamoeba or balamuthia trophozoites and/or cysts
|
|
WO2020081723A1
|
|
Carbon monoxide prodrugs for the treatment of medical disorders
|
|
WO2020047354A1
|
|
Continuous restricted boltzmann machines
|
|
WO2020041500A1
|
|
Treatment of flavivirus infections in humans using mus musculus resistant 2'-5' oligoadenylate synthetase 1b
|
|
US2020056991A1
|
|
Detection of melanoma and lymphoma by atr-ftir spectroscopy
|
|
EP3784660A1
|
|
Environmentally-friendly hydroazidation of olefins
|
|
EP3806836A1
|
|
Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics
|
|
EP3787655A1
|
|
Compositions and methods related to rhamnus prinoides (gesho) extract for the inhibition of polymicrobial biofilm formation
|
|
WO2019213579A1
|
|
Inhibitors of rsv replication and applications thereof
|
|
US2021052718A1
|
|
Respiratory syncytial virus (rsv) vaccines
|
|
WO2019147664A1
|
|
Compositions for the removal of heavy metals
|
|
EP3713643A2
|
|
System and methods to promote cellular regeneration following ischemia
|
|
WO2019084323A1
|
|
Enrichment-triggered chemical delivery system
|
